Back to Search
Start Over
FRI350 - Potential biomarkers of response in chronic hepatitis B patients who achieved HBeAg loss upon treatment with toll-like receptor 8 (TLR8) agonist selgantolimod.
- Source :
-
Journal of Hepatology . 2020 Supplement 1, Vol. 73, pS571-S572. 2p. - Publication Year :
- 2020
- Subjects :
- *CHRONIC hepatitis B
*TOLL-like receptors
*BIOMARKERS
*HEPATITIS A
*VIRAL hepatitis
Subjects
Details
- Language :
- English
- ISSN :
- 01688278
- Volume :
- 73
- Database :
- Academic Search Index
- Journal :
- Journal of Hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 145884856
- Full Text :
- https://doi.org/10.1016/S0168-8278(20)31616-0